EpiCast Report: Type 2 Diabetes - Epidemiology

Forecast to 2024 Now Available at iData Insights

EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2024 Summary Diabetes is one of the most common
non-communicable diseases worldwide and is an escalating public health problem globally, with an estimated 387
million people living with diabetes worldwide. At least 90% of all diabetes cases are T2D. Risk factors for T2D are
broadly categorized as modifiable and non-modifiable risk factors. Lifestyle factors such as obesity, physical inactivity
and dietary habits are modifiable risk factors and therefore it can be controlled or prevented. Non-modifiable risk
factors, such as family history and advancing age, can also put a person at high risk for developing the disease. T2D
is also associated with several comorbidities, such as CKD, CVD, hypertension, and dyslipidemia, which can worsen
the quality of life of the patient, and can lead to poor therapeutic outcomes. GlobalData epidemiologists forecast an
increase in the diagnosed prevalent cases of T2D in the 9MM, from 113,536,653 diagnosed prevalent cases in 2014
to 148,340,916 diagnosed prevalent cases in 2024, with an Annual Growth Rate (AGR) of 3.07%. GlobalData
epidemiologists attribute the growth in prevalent cases to an increase in the prevalence of risk factors associated with
T2D, such as obesity and physical inactivity, together with increased urbanization. GlobalData s epidemiological
analysis provides a country-specific forecast for the diagnosed prevalent cases of T2D in the 9MM during 2014-2024.
GlobalData epidemiologists made sure that all the country-specific studies reported diagnosed prevalence of all
diabetes or T2D. GlobalData s epidemiological forecast for diagnosed prevalence of T2D in the 9MM is supported
by longitudinal historical data obtained from studies in respective countries, which provide detailed insights into the
epidemiology of the disease in these countries. Furthermore, GlobalData epidemiologists used nationally
representative, country-specific studies published in peer-reviewed journals or national healthcare databases to
forecast prevalent cases of diagnosed T2D in all of the major markets in this analysis. Scope - The Type 2 Diabetes
(T2D) EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for T2D in the nine
major markets (9MM) (US, France, Germany, Italy, Spain, UK, Japan, China, and India). It includes a 10-year
epidemiological forecast of the one-year prevalent cases of T2D segmented by sex, age (in five-year increments
beginning at 20 years and ending at =85 years), and comorbidities in these markets. - The T2D epidemiology report
is written and developed by Masters- and PhD-level epidemiologists. - The EpiCast Report is in-depth, high quality,
transparent and market-driven, providing expert analysis of disease trends in the 10MM. Reasons to buy The Type 2
Diabetes (T2D) EpiCast series will allow you to - - Develop business strategies by understanding the trends shaping
and driving the global T2D market. - Quantify patient populations in the global T2D market to improve product design,
pricing, and launch plans. - Organize sales and marketing efforts by identifying the sex and age groups that present
the best opportunities for T2D therapeutics in each of the markets covered.
Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landing-page.php?id=124181/epicastreport-type-2-diabetes-epidemiology-forecast-to-2024
To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landing-page.php?id=124181/epicastreport-type-2-diabetes-epidemiology-forecast-to-2024
Table of Contents
1 Table of Contents
4 1.1 List of Tables
5 1.2 List of Figures
6 2 Introduction
7 2.1 Catalyst
7 2.2 Related Reports
8 2.3 Upcoming Reports
9 3 Epidemiology
10 3.1 Disease Background
10 3.2 Risk Factors and Comorbidities

11 3.3 Global Trends

12 3.3.1 US
12 3.3.2 5EU
13 3.3.3 Japan
13 3.3.4 China and India
14 3.4 Forecast Methodology
15 3.4.1 Sources Used for Diagnosed Prevalence of T2D
20 3.4.2 Sources Not Used
31 3.4.3 Forecast Assumptions and Methods, Diagnosed Prevalent Cases of T2D
32 3.5 Epidemiological Forecast for T2D (2014-2024)
43 3.5.1 Diagnosed Prevalent Cases of T2D
43 3.5.2 Age-Specific Diagnosed Prevalent Cases of T2D
45 3.5.3 Sex-Specific Diagnosed Prevalent Cases of T2D
47 3.5.4 Age-Standardized Diagnosed Prevalence of T2D
49 3.5.5 Prevalent Cases of CKD Among Diagnosed T2D Cases
51 3.5.6 Prevalent Cases of CVD Among Diagnosed T2D Cases
51 3.5.7 Prevalent Cases of Overweight/Obesity Among Diagnosed T2D Cases
52 3.5.8 Prevalent Cases of Hypertension Among Diagnosed T2D Cases
53 3.5.9 Prevalent Cases of Dyslipidemia Among Diagnosed T2D Cases
54 3.6 Discussion
55 3.6.1 Epidemiological Forecast Insight
55 3.6.2 Limitations of the Analysis
56 3.6.3 Strengths of the Analysis
56 4 Appendix 58 4.1 Bibliography
58 4.2 About the Authors
65 4.2.1 Epidemiologists
65 4.2.2 Reviewers
65 4.2.3 Global Director of Therapy Analysis and Epidemiology
66 4.2.4 Global Head of Healthcare
67 4.3 About GlobalData
68 4.4 About EpiCast
68 4.5 Disclaimer
Read More @ http://www.idatainsights.com/reports-landing-page.php?id=124181/epicast-report-type-2-diabetesepidemiology-forecast-to-2024

About Us:
iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research
information aggregator and marketing research consulting firm. We conduct both primary and secondary research.
Our work does not end with research it is also involved in distributing reports for different companies . We provide
actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be
a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that
will make a difference to their bottom line.

Contact Us:
iData Insights
Tel: 1-866-237-2965
Web: http://www.idatainsights.com
Email: info@idatainsights.com

About iData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to
provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our
promise to provide results that are essential to the success of your company. We believe that by doing so, we will
earn the trust of our clients for future projects.